Septal Defect Occluder Market Report 2024 (Global Edition)

Global Septal Defect Occluder Market Report 2024 Market Size Split by Product (Atrial Septal Defect Occluder, Ventricular Septal Defect Occluder, Patent Ductus Arteriosus Occluder), by Application (Ad...

Septal Defect Occluder Market Report Description

We have various report editions of Septal Defect Occluder Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Septal Defect Occluder Market

The competitive landscape of the Septal Defect Occluder market is characterized by intense rivalry among manufacturers striving to innovate and capture market share. Key strategies include product development, strategic partnerships, and geographical expansion, driven by the pursuit of technological advancements and meeting evolving patient needs.

 

Top Companies Market Share in Septal Defect Occluder Industry: (In no particular order of Rank)

• Abbott Laboratories
• W. L. Gore & Associates
• AGA medicine
• Pioneer Technology Co
• Vascular Innovations
• Universal Health Care
• Beijing Huayi Shengjie
• PFM Medical
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Septal Defect Occluder Market

Which Region will dominate the Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue due to advanced healthcare infrastructure, high healthcare expenditure, and a significant prevalence of congenital heart defects. Increasing awareness among both patients and healthcare professionals, coupled with favourable reimbursement policies, drives market growth. Moreover, on-going technological advancements and a strong presence of key market players contribute to the region's market dominance. Additionally, rising adoption of minimally invasive procedures and a growing elderly population prone to acquired heart defects further boost sales in the region.

Which Region is Expanding at the Fastest CAGR?

The Asia-Pacific is the fastest growing region due to several factors. Firstly, improving healthcare infrastructure and rising healthcare spending across countries like China, India, and Japan facilitate increased access to advanced cardiac interventions. Secondly, a growing prevalence of congenital heart defects in the region, driven by factors like changing lifestyles and environmental factors, fuels demand for occluder devices. Furthermore, technological advancements coupled with increasing awareness about minimally invasive procedures contribute to the market's rapid expansion. Additionally, favourable government initiatives aimed at improving healthcare facilities and addressing unmet medical needs further propel sales growth in the Asia-Pacific region.

The current report Scope analyzes Septal Defect Occluder Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Septal Defect Occluder Market

According to Cognitive Market Research, the global septal defect occluder market size was estimated at USD XX Million out of which North America held the major market of around 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.5% from 2024 to 2031. Sales of septal defect occluders in North America are set to rise due to advanced healthcare infrastructure and increasing adoption of transcatheter procedures. Additionally, favourable reimbursement policies and expanding awareness about minimally invasive treatments drive market growth. Furthermore, strategic collaborations between healthcare providers and device manufacturers stimulate innovation and market penetration. The highest market share segment, such as atrial septal defect occluder, will witness significant growth in North America owing to its efficacy in treating prevalent congenital heart defects and strong demand from patients and clinicians.

Country Analysis

• According to Cognitive Market Research, The United States septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.3% during the forecast period. Sales of septal defect occluders in the U.S. will increase due to advanced healthcare infrastructure, rising prevalence of congenital heart defects, and favourable reimbursement policies, driving adoption of innovative treatments.
• Canada septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.3% during the forecast period. In Canada, sales of septal defect occluders will rise owing to increasing awareness about minimally invasive procedures, expanding healthcare access, and growing demand for advanced cardiac interventions among patients and clinicians.
• Mexico septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period.

 

Europe Septal Defect Occluder Market

According to Cognitive Market Research, with a market value of USD XX million in 2024 and projected to expand at a compound annual growth rate (CAGR) of 2.8% from 2024 to 2031. Europe accounted for a share of around 30% of the global market size of USD XX million. In Europe, sales of septal defect occluders are poised for growth due to increasing healthcare expenditure and advancements in device technology. Additionally, expanding geriatric population and rising incidence of acquired heart defects contribute to higher demand. Moreover, stringent regulatory standards ensure the safety and efficacy of occluder devices, fostering market growth. Furthermore, expanding access to specialized cardiac care centres and favourable reimbursement policies drive adoption rates. The highest market share segment, such as metal occluders, will experience notable growth in Europe driven by their proven efficacy, durability, and widespread acceptance among healthcare providers.

• The United Kingdom septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.6% during the forecast period. The UK market will see an increase in septal defect occluder sales due to advancements in medical technology, expanding geriatric population, and government initiatives aimed at improving cardiac care infrastructure and services.
• France septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.0% during the forecast period.
• Germany septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. In Germany, sales of septal defect occluders will increase due to robust healthcare system, growing prevalence of congenital heart defects, and high demand for minimally invasive cardiac interventions among patients and healthcare providers.
• Italy septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.2% during the forecast period.
• Russia septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 1.8% during the forecast period.
• Spain septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 1.9% during the forecast period.
• Luxembourg septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.9% during the forecast period.
• Portugal septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.6% during the forecast period.
• Greece septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.1% during the forecast period.
• Rest of Europe septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 1.5% during the forecast period.

 

Asia Pacific Septal Defect Occluder Market

According to Cognitive Market Research, the global septal defect occluder market size was estimated at USD XX Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.3% from 2024 to 2031. The Asia Pacific region will see a surge in sales of septal defect occluders due to improving healthcare infrastructure and rising awareness about cardiac interventions. Furthermore, increasing prevalence of congenital heart defects in paediatric populations and advancements in medical technology drive market growth. Additionally, expanding healthcare expenditure and government initiatives to enhance healthcare access further stimulate demand. Moreover, collaborations between regional and international medical institutions promote knowledge exchange and technology transfer. The highest market share segment, such as transcatheter occluders, will witness significant growth in Asia Pacific as patients and healthcare providers increasingly prefer minimally invasive treatments for septal defects.

• According to Cognitive Market Research, China septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. Sales of septal defect occluders in China will rise owing to expanding healthcare infrastructure, increasing incidence of congenital heart defects, and government initiatives to improve access to advanced cardiac care across the country.
• Japan septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period.
• India septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 8.1% during the forecast period. In India, septal defect occluder sales will increase due to growing healthcare expenditure, rising awareness about cardiac interventions, and increasing demand for minimally invasive treatments among patients and healthcare professionals.
• South Korea septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 5.4% during the forecast period.
• Australia septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period.
• South East Asia septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period.
• Rest of Asia Pacific septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 6.1% during the forecast period.

 

South America Septal Defect Occluder Market

According to Cognitive Market Research, the global septal defect occluder market size was estimated at USD XX Million out of which Latin America market of around 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031. Sales of septal defect occluders in Latin America are expected to increase due to improving healthcare infrastructure and rising awareness about cardiac interventions. Moreover, growing prevalence of congenital heart defects in paediatric populations and increasing healthcare spending contribute to higher demand. Additionally, expanding access to specialized cardiac care centres and government initiatives to improve healthcare access further stimulate market growth. The highest market share segment, such as polymer occluders, will see notable growth in Latin America owing to their flexibility, biocompatibility, and reduced risk of complications, which are particularly valued in the region.

• According to Cognitive Market Research, Brazil septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.3% during the forecast period. Sales of septal defect occluders in Brazil will rise due to expanding healthcare access, growing prevalence of congenital heart defects, and increasing adoption of transcatheter procedures in cardiac care across the country.
• Argentina septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.6% during the forecast period. In Argentina, septal defect occluder sales will increase owing to improving healthcare infrastructure, rising awareness about cardiac interventions, and government efforts to enhance access to specialized cardiac care services.
• Colombia septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period.
• Peru septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.9% during the forecast period.
• Chile septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period.
• Rest of Latin America septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 2.8% during the forecast period.

 

Middle East and Africa Septal Defect Occluder Market

According to Cognitive Market Research, the global Septal defect occluder market size was estimated at USD XX Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031. In the MEA region, sales of septal defect occluders are set to rise due to increasing healthcare investment and improving access to specialized cardiac care. Additionally, rising prevalence of congenital heart defects and advancements in medical technology drive market growth. Furthermore, growing awareness about cardiac interventions and expanding healthcare infrastructure in urban centres contribute to higher demand. The highest market share segment, such as surgical occluders, will experience significant growth in MEA driven by the preference for open surgical approaches in some regions and the availability of specialized surgical centres.

• According to Cognitive Market Research, GCC Countries septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. Sales of septal defect occluders in GCC Countries will increase due to high healthcare spending, growing prevalence of cardiovascular diseases, and government initiatives to develop advanced cardiac care infrastructure and services.
• Egypt septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 4.3% during the forecast period.
• South Africa septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. In South Africa, septal defect occluder sales will rise owing to improving access to specialized cardiac care, increasing incidence of congenital heart defects, and rising adoption of minimally invasive cardiac interventions among patients and healthcare providers.
• Turkey septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period.
• Nigeria septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.1% during the forecast period.
• Rest of MEA septal defect occluder market had a market share of USD xx million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period.

 

Septal Defect Occluder Market Analysis

Septal Defect Occluder Market Type Segment Analysis

According to Cognitive Market Research, atrial septal defect occluder held the major market share over the forecast period due to their established efficacy in treating a prevalent type of congenital heart defect. Increasing incidence rates of atrial septal defects, coupled with advancements in occluder technology, drive market expansion. Additionally, the expanding application of transcatheter procedures, along with improved reimbursement policies, further boosts sales. Moreover, the versatility and ease of deployment of atrial septal defect occluders contribute to their sustained dominance in the market.

Patent ductus arteriosus occluder is the fastest-growing category over the forecast period, owing to several factors. Firstly, rising awareness and early diagnosis of patent ductus arteriosus conditions contribute to increased demand for occluder devices. Secondly, advancements in device design and materials enhance treatment outcomes, driving adoption rates. Additionally, the expanding pediatric population and improving healthcare infrastructure in emerging economies fuel market growth. Furthermore, the growing preference for minimally invasive transcatheter procedures over traditional surgery further accelerates sales in this segment.

• Atrial Septal Defect Occluder
• Ventricular Septal Defect Occluder
• Patent Ductus Arteriosus Occluder

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Septal Defect Occluder Industry. Request a Free Sample PDF!

Septal Defect Occluder Market Application Segment Analysis

According to Cognitive Market Research, pediatrics hold a prominent market share due to several factors. The increasing prevalence of congenital heart defects in children, coupled with early diagnosis and intervention, drives demand. Moreover, advancements in paediatric cardiac care and minimally invasive procedures enhance treatment accessibility and outcomes. Additionally, expanding healthcare infrastructure and improving awareness among caregivers contribute to sustained sales growth in this segment.

Adults is the fastest-growing category over the forecast period due to various factors. Firstly, the aging population contributes to a higher prevalence of acquired heart defects necessitating occluder interventions. Secondly, advancements in occluder technology, such as improved device designs and materials, enhance treatment outcomes and safety profiles, driving adoption rates among adult patients. Additionally, the increasing adoption of minimally invasive transcatheter procedures in adult cardiac care further accelerates sales growth in this segment.

• Adults
• Pediatrics

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Septal Defect Occluder Material Segment Analysis

According to Cognitive Market Research, metal held the major market share over the forecast period due to their established efficacy, durability, and widespread acceptance. The robustness of metal occluders makes them a preferred choice for many healthcare providers, especially in regions with stringent regulatory requirements. Additionally, the familiarity of metal occluders among clinicians and their proven long-term performance contribute to sustained sales growth in this segment.

Polymer is the fastest-growing category over the forecast period due to several factors. Polymer occluders offer advantages such as flexibility, biocompatibility, and reduced risk of complications, making them increasingly favoured by both patients and healthcare providers. Moreover, on-going advancements in polymer technology, including the development of novel materials and delivery systems, drive adoption rates. Additionally, the expanding application of polymer occluders in minimally invasive procedures further accelerates sales growth in this segment.

• Metal
• Polymer

Septal Defect Occluder Delivery Segment Analysis

According to Cognitive Market Research, transcatheter held the major market share over the forecast period due to their minimally invasive nature, shorter recovery times, and reduced risk of complications compared to surgical interventions. The increasing adoption of transcatheter procedures by healthcare providers and patients, coupled with advancements in device technology and imaging techniques, further contribute to sustained sales growth in this segment. Additionally, expanding reimbursement coverage and growing patient preference for less invasive treatments drive market expansion.

Surgical is the fastest-growing category over the forecast period due to several factors. While transcatheter procedures dominate, surgical occluders continue to see growth due to their applicability in complex cases and the preference of some surgeons for open surgical approaches. Additionally, advancements in surgical techniques and perioperative care contribute to improved outcomes and safety profiles, driving adoption rates. Moreover, the availability of specialized surgical centres and expertise further accelerates sales growth in this segment.

• Transcatheter
• Surgical

Septal Defect Occluder End User Segment Analysis

According to Cognitive Market Research, hospitals held the major market share over the forecast period due to several factors. Hospitals serve as primary centres for cardiac interventions, offering a wide range of specialized services and expertise. The availability of advanced diagnostic tools, comprehensive care facilities, and skilled healthcare professionals in hospitals contributes to higher procedure volumes and occluder sales. Additionally, hospitals often attract a larger patient pool, including those with complex medical needs, further boosting sales in this segment.

Ambulatory surgical centres is the fastest-growing category over the forecast period owing to various factors. ASCs offer several advantages, including convenience, cost-effectiveness, and reduced waiting times for procedures. Patients increasingly prefer ASCs for minor surgeries and outpatient procedures, including occluder implantations, due to their streamlined processes and lower infection risks. Moreover, advancements in occluder technology and procedural techniques enable more occluder interventions to be performed in ASCs, contributing to rapid sales growth in this segment.

• Hospitals
• Cardiology Centers
• Ambulatory Surgical Centers

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion